Verdence Capital Advisors’s Celgene Corp CELG Stock Holding History

Verdence Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,731	Closed	-$258K	–	307
2019 Q1	$258K	Sell	2,731 -557	-17%	-$48.7K	0.07%	220
2018 Q4	$211K	Sell	3,288 -573	-15%	-$42.3K	0.06%	224
2018 Q3	$346K	Sell	3,861 -31,987	-89%	-$2.83M	0.09%	193
2018 Q2	$2.85M	Sell	35,848 -1,536	-4%	-$128K	0.69%	41
2018 Q1	$3.33M	Sell	37,384 -149	-0.4%	-$14.3K	0.8%	34
2017 Q4	$3.92M	Buy	+37,533	New	+$4.24M	0.93%	32

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Verdence Capital Advisors's CELG Position: Q2 2019 in Review

Verdence Capital Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,731 shares — an estimated $258K sold.

Verdence Capital Advisors first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $3.92M in Q4 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Verdence Capital Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Verdence Capital Advisors sold 2,731 Celgene Corp shares in Q2 2019, an estimated $258K.
Verdence Capital Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
Verdence Capital Advisors's Celgene Corp position peaked at $3.92M in Q4 2017.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Verdence Capital Advisors's 13F filing for Q2 2019, filed 2 Mar 2020.